Oncolytics Biotech Inc ONCY

Investor Presentation has been updated on their website.

[askretka]

CAR-T stuff on their now. Pursuing a partnership, but we already knew that. Plus 3 new immunotherapies that Pelareorep may work to enhance. 1. Bispecific Antibodies ( This is reallly interesting, more on this later researching) 2. PARP inhibitors. 3. CDK4/6 inhibitors. Cheers!

[Noteable]

CAR T therapy targeting solid tumors is restrained by limited infiltration and persistence of those cells in the tumor microenvironment (TME). Dr. RIchard Vile's team at the Mayo Clinic have demonstrated that CAR-T cells loaded with the OV pelareorep followed by a "booster shot" of pelareorep was able to "cure" 100% of the subjects of their solid tumors. ONCY's

[westcoast1000]

I have looked at the successive ONCY investor presentations for many years. This is the best and most informative one they have ever had. That makes sense because they keep improving them. But the additional opportunities they mention are new and very encouraging. Let us remember four things when feeling dismayed at the time this is all taking: - we are entering the world of immunotherapy for

[askretka]

Good post Wescoast I couldn't have said it better myself. GOOD Summary. The fact we have the safest bug is a big deal. And by giving it by IV it should go after secondary and tertiary cancers or more. The " Mets" Short of metastasizing cancers are a big deal and becoming more common as some treatments are working and people are living longer and redevelopong cancers in other parts of

[HCallahann44]

Thanks Westcoast---I get lumped in with the bashers here but I am willing to bet I have the largest position of any poster here....everything looks so positive....but then the insiders are just not loading....and that continues to be a redflag...Pela seems to have so many applications--and its safe....why aren't they loading the wagons????